Search

everythinglearnresearchcommunity

for

Search:↓

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Stem cells help control the immune response to improve wound healing.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

ILC1-like cells may contribute to hair loss in alopecia areata.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.

Alopecia areata is linked to reduced T cell function and auto-immunity.

A new test using NOS2 and CCL27 genes can better diagnose and treat psoriasis and eczema.

Inflammation in hair follicles is a key risk factor for developing common baldness.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.